Ultralow-Dose Radiation Therapy Reduces Bone Pain in Myeloma While Preserving Bone Marrow

This report highlights that ultralow-dose radiation therapy achieves an 86% pain response rate at six months in patients with myeloma. The treatment also shows low rates of adverse events and the need for re-irradiation, indicating its effectiveness and safety in managing bone pain while preserving bone marrow.

Originally published by gnews